A powerhouse panel of licensing executives brought their vast IP experience to a dynamic discussion covering the issues most requested by LES Meeting attendees: valuing deals, co-development, and sponsorship and licensing from a university perspective. The panel of experienced dealmakers was moderated by Leslie Stolz, VP Business Development, Sutro Biopharma, Inc., and included:
• Kelly Longo, Director, Worldwide Business Development, Pfizer
• Jane Devereax, Senior Director, Corporate Licensing, Merck
• Katherine Ku, Director, Stanford University Office of Technology Licensing
• Chris Searcy, Sr. VP Corporate Development, Valeritas, Inc.
• Nagesh Mahanthappa, VP Corporate Development, Avila Therapeutics